Semler Scientific (SMLR) 10-Q 4 May 15 2015 Q1 Quarterly report Financial data

Document_and_Entity_Informatio

Document and Entity Information	3 Months Ended
	Mar. 31, 2015	Apr. 30, 2015
Document And Entity Information [Abstract]
Entity Registrant Name	Semler Scientific, Inc.
Entity Central Index Key	1554859
Trading Symbol	smlr
Current Fiscal Year End Date	-19
Entity Filer Category	Smaller Reporting Company
Entity Common Stock, Shares Outstanding		4,976,517
Document Type	10-Q
Document Period End Date	31-Mar-15
Amendment Flag	FALSE
Document Fiscal Year Focus	2015
Document Fiscal Period Focus	Q1

Condensed_Statements_of_Operat

Condensed Statements of Operations (Unaudited) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Income Statement [Abstract]
Revenue	$1,202	$837
Operating expenses:
Cost of revenue	220	155
Engineering and product development	309	229
Sales and marketing	1,228	746
General and administrative	793	497
Total operating expenses	2,550	1,627
Loss from operations	-1,348	-790
Other expense:
Interest and other expense	-24	-27
Other expense	-24	-27
Net loss	($1,372)	($817)
Net loss per share, basic and diluted (in dollars per share)	($0.29)	($0.36)
Weighted average number of shares used in computing basic and diluted loss per share (in shares)	4,763,573	2,240,703

Condensed_Balance_Sheets

Condensed Balance Sheets (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Current Assets:
Cash	$3,061	$4,156
Restricted Cash	2,100	2,100
Trade accounts receivable, net of allowance for doubtful accounts of $54 and $28, respectively	356	355
Prepaid expenses and other current assets	144	135
Total current assets	5,661	6,746
Assets for lease, net	662	673
Property and equipment, net	26	9
Long-term deposits	17	17
Deferred financing costs	37	55
Total assets	6,403	7,500
Current liabilities:
Accounts payable	89	89
Accrued expenses	1,226	1,363
Deferred revenue	493	612
Loans payable	2,000	2,000
Total current liabilities	3,808	4,064
Stockholders' equity:
Common stock, $0.001 par value; 50,000,000 shares authorized; 4,858,517 and 4,741,017 shares issued, and 4,833,517 and 4,716,017 outstanding (net of treasury shares of 25,000 and 25,000), respectively	5	5
Additional paid-in capital	17,829	17,298
Accumulated deficit	-15,239	-13,867
Total stockholders' equity	2,595	3,436
Total liabilities and stockholders' equity	$6,403	$7,500

Condensed_Balance_Sheets_Paren

Condensed Balance Sheets (Parentheticals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, except Share data, unless otherwise specified
Allowance for doubtful accounts on trade accounts receivable (in dollars)	$54	$28
Common stock, par value (in dollars per share)	$0.00	$0.00
Common stock, shares authorized	50,000,000	50,000,000
Common stock, shares issued	4,858,517	4,741,017
Common stock, shares outstanding	4,833,517	4,716,017
Treasury stock, shares	25,000	25,000

Condensed_Statements_of_Cash_F

Condensed Statements of Cash Flows (Unaudited) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	($1,372)	($817)
Reconciliation of Net Loss to Net Cash Used in Operating Activities:
Amortization of deferred financing costs	18	23
Depreciation	59	47
Loss on disposal of assets for lease	25	16
Allowance for doubtful accounts	51	50
Stock-based compensation expense	33
Changes in Operating Assets and Liabilities:
Trade accounts receivable	-52	21
Prepaid expenses and other current assets	-9	-176
Accounts payable		-116
Accrued expenses	-137	58
Deferred revenue	-119	-132
Net Cash Used in Operating Activities	-1,503	-1,026
CASH FLOWS FROM INVESTING ACTIVITIES:
Additions to property and equipment	-19	-4
Purchase of assets for lease	-71	-116
Net Cash Used in Investing Activities	-90	-120
CASH FLOWS FROM FINANCING ACTIVITIES:
Issuance of common stock	498	10,010
Offering costs		-1,959
Payments of loans payable		-15
Payments of equipment leases		-12
Net Cash Provided by Financing Activities	498	8,024
INCREASE (DECREASE) IN CASH	-1,095	6,878
CASH, BEGINNING OF PERIOD	4,156	734
CASH, END OF PERIOD	3,061	7,612
Cash paid for interest	8	4
Supplemental disclosure of noncash financing activity:
Conversion of preferred stock into common stock		$6,707

Basis_of_Presentation

Basis of Presentation	3 Months Ended
	Mar. 31, 2015
Basis Of Presentation [Abstract]
Basis of Presentation		1	Basis of Presentation
	Semler Scientific, Inc., a Delaware corporation (“Semler” or “the Company”), prepared the unaudited interim financial statements included in this report in accordance with United States generally accepted accounting principles (“U.S. GAAP”) and applicable rules and regulations of the Securities and Exchange Commission (“SEC”) for interim financial reporting. Certain information and note disclosures normally included in the financial statements prepared in accordance with GAAP have been condensed or omitted pursuant to such rules and regulations. As such, the information included in this quarterly report on Form 10-Q should be read in conjunction with the audited financial statements and notes thereto included in the Company’s annual report on Form 10-K filed with the SEC on February 13, 2015 (the “Annual Report”). The balance sheet as of December 31, 2014 included in this report has been derived from the audited financial statements included in the Annual Report. In the opinion of management, these financial statements include all adjustments (consisting of normal recurring adjustments) necessary for a fair statement of the financial position, results of operations and cash flows for the periods presented. The results of operations for the interim periods shown in this report are not necessarily indicative of the results that may be expected for any future period, including the full year. Items in prior year financial statements have been adjusted to conform with the current year presentation.
	Initial Public Offering
	In February 2014, the Company completed its initial public offering (“IPO”) in which it issued and sold 1,430,000 shares of its common stock at a public offering price of $7.00 per share. The Company received net proceeds of $7,403 after deducting underwriting discounts and commissions of $848 and other offering expenses of approximately $1,759. The Company incurred $648 of the offering expenses in 2013, and incurred $1,959 of such expenses in the first quarter of 2014. The Company granted the underwriter an overallotment option to acquire an additional 214,500 shares of its common stock, which expired April 6, 2014 unexercised, and issued the underwriter warrants to acquire an aggregate of 71,500 shares of its common stock at an exercise price of $8.75 per share, which became exercisable February 20, 2015 and expire February 20, 2019. Upon the closing of the IPO, all shares of the Company’s then-outstanding Series A convertible Preferred Stock (1,468,402), Series A-1 convertible Preferred Stock (293,750) and Series A-2 convertible Preferred Stock (250,000) automatically converted into an aggregate of 2,012,152 shares of common stock. In addition, the Company’s then outstanding warrants to acquire an aggregate of 1,067,210 shares of Series A convertible Preferred Stock and 228,656 shares of Series A-1 convertible Preferred Stock were cashlessly exercised at the IPO price for an aggregate of 479,115 shares of common stock. All other outstanding warrants of the Company became exercisable for common stock effective upon the IPO in accordance with their terms.

Going_Concern

Going Concern	3 Months Ended
	Mar. 31, 2015
Going Concern [Abstract]
Going Concern		2	Going Concern
	The Company has incurred recurring losses since inception and expects to continue to incur losses as a result of costs and expenses related to the Company’s marketing and other promotional activities, research and continued development of its product. As of March 31, 2015, the Company has working capital of $1,853, cash and restricted cash of $5,161 (which includes $2,100 of restricted cash) and stockholders’ equity of $2,595. The Company’s principal sources of cash have included the issuance of equity securities, and to a lesser extent, borrowings under loan agreements and revenue from leasing its product. To increase revenues, the Company’s operating expenses will continue to grow and, as a result, the Company will need to generate significant additional revenues to achieve profitability. In order to execute on its business plan, and given current available cash, the Company anticipates that it will need to raise additional capital.
	The Company’s financial statements as of March 31, 2015 have been prepared under the assumption that the Company will continue as a going concern. The Company’s ability to continue as a going concern is dependent upon its ability to obtain additional equity or debt financing, attain further operating efficiencies and, ultimately, to generate additional revenue. The financial statements do not include any adjustments that might result from the outcome of this uncertainty. The Company can give no assurances that additional capital that the Company is able to obtain, if any, will be sufficient to meet the Company’s needs. If the Company is unable to raise additional capital within the next twelve months to continue to fund operations at its current cash expenditure levels, the Company’s operations will need to be curtailed. The foregoing conditions raise substantial doubt about the Company’s ability to continue as a going concern.

Assets_for_Lease

Assets for Lease	3 Months Ended
	Mar. 31, 2015
Leases, Capital [Abstract]
Assets for Lease		3	Assets for Lease
	Assets for lease consist of the following:
			March 31,			December 31,
			2015			2014
	Assets for lease		$	988		$	956
	Less: Accumulated Depreciation			(326	)		(283	)
	Assets for lease, net		$	662		$	673
	Depreciation expense amounted to $57 and $47 for the three months ended March 31, 2015 and March 31, 2014, respectively. Reduction to accumulated depreciation for returned items was $14 and $16 for the three months ended March 31, 2015 and March 31, 2014, respectively.

Deferred_Financing_Costs

Deferred Financing Costs	3 Months Ended
	Mar. 31, 2015
Deferred Finance Costs [Abstract]
Deferred Financing Costs		4	Deferred Financing Costs
	As of March 31, 2015 and December 31, 2014, deferred financing costs have the net amounts of $37 and $55, respectively. The amounts amortized to interest expense were $18 and $23 for the three months ended March 31, 2015 and March 31, 2014, respectively. Per details in Note 6, leases were paid off early due to the opening of a new line of credit, resulting in acceleration of the expensing of the outstanding deferred financing costs.

Accrued_Expenses

Accrued Expenses	3 Months Ended
	Mar. 31, 2015
Accrued Liabilities, Current [Abstract]
Accrued Expenses		5	Accrued Expenses
	Accrued expenses consist of the following:
			March 31,		December 31,
			2015		2014
	Offering Costs		$	317	$	407
	Compensation			569		721
	Miscellaneous Accruals			340		235
	Total Accrued Expenses		$	1,226	$	1,363
	The accumulated offering costs that were accrued pertain to consulting fees associated with securing equity financing for the Company prior to the IPO. Prior to becoming Chief Executive Officer (“CEO”), the Company’s current CEO performed consulting services for the Company, which included managing finance, sales, marketing, operational and strategic planning for our company, as well as assistance and strategic guidance in securing financing.

Commitments_and_Contingencies

Commitments and Contingencies	3 Months Ended
	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	6	Commitments and Contingencies
	Facilities Leases
	For the three months ended March 31, 2015, the Company recognized $32 in facilities lease expense. The Company had no material facilities leases for the three months ended March 31, 2014 and had no rent expense for such period. On September 23, 2014, the Company entered into a 36-month lease agreement for office space for the sales and marketing team located in Menlo Park, CA. The lease term commenced February 1, 2015 and is effective through January 31, 2018. Payments required under the terms of the lease are $17.0 per month from February 2015 to January 2016, $17.5 per month from February 2016 to January 2017, and $18.0 per month from February 2017 to January 2018. The Company anticipates total future lease payments of $186.6 for the year ended December 31, 2015; $209.1 for the year ended December 31, 2016; $215.4 for the year ended December 31, 2017; and $18.0 for the year ended December 31, 2018.
	Equipment Leases and Loans Payable
	On February 9, 2011, the Company entered into an Equipment Finance Agreement with U.S. Bancorp Business Equipment Finance Group. Pursuant to the agreement, the Company obtained a $39 secured loan for a 48-month term that had an annual fixed interest rate of 13%. The loan was secured by the related leased equipment. Under the agreement, the Company made monthly payments consisting of $1 of principal plus any accrued interest. The agreement provided for customary events of default. This loan was personally guaranteed by a Company director and a principal stockholder of the Company. This facility was retired in September 2014. At March 31, 2014, the Company had outstanding borrowings of $10.
	On May 27, 2011, the Company entered into an Equipment Finance Agreement with U.S. Bancorp Business Equipment Finance Group. Pursuant to the Agreement, the Company obtained a $109 secured loan for a 60-month term that had an annual fixed interest rate of 6%. The loan was secured by the related leased equipment. Under the Agreement, the Company made monthly payments consisting of $2 of principal plus any accrued interest. The Agreement provided for customary events of default. This loan was personally guaranteed by a Company director and a principal stockholder of the Company. This facility was retired in September 2014. At March 31, 2014, the Company had outstanding borrowings of $50.
	At various dates in 2011, the Company entered into Lease Agreements with Lease Corporation of America. Pursuant to these agreements, the Company obtained an aggregate amount of $66 for a 60-month term that had variable annual interest rates of approximately 14%. The leases were secured by the related leased equipment. Under the agreements, the Company made monthly payments of approximately $1 of principal plus any accrued interest. The agreements provided for customary events of default. The leases were personally guaranteed by a principal stockholder of the Company. This facility was retired in September 2014. At March 31, 2014, the Company had outstanding borrowings of $40.
	On June 17, 2011, the Company entered into a loan agreement with First Republic Bank. Pursuant to the loan agreement, the Company obtained a $150 secured loan for a 60-month term that had a variable interest rate based on First Republic’s Prime plus a spread of 1.75% p.a. and a floor of 3.25% p.a. The initial interest rate was 5% p.a. Under the loan agreement, the Company made monthly payments consisting of $3 of principal plus any accrued interest. The loan agreement provided for customary events of default. This loan was personally guaranteed by a principal stockholder of the Company. This loan agreement was retired in September 2014. At March 31, 2014, the Company had outstanding borrowings of $68.
	On September 13, 2011, the Company entered into an additional loan agreement with First Republic Bank. Pursuant to the loan agreement, the Company obtained a $150 loan for a 60-month term that had a variable annual interest rate based on First Republic’s Prime plus a spread of 1.75% and a floor of 3.25%. The initial interest rate was 5%. Under the loan agreement, the Company made monthly payments consisting of $3 of principal plus any accrued interest. The loan agreement provided for customary events of default. This loan was personally guaranteed by a principal stockholder of the Company. This loan agreement was retired in September 2014. At March 31, 2014, the Company had outstanding borrowings of $75.
	On September 30, 2014, the Company entered into a revolving line of credit with First Republic Bank. Pursuant to the line of credit agreement, the Company may borrow up to $2,000 for a 12-month term that has a variable annual interest rate based on First Republic’s Prime less a spread of 2.0% p.a. The initial interest rate is 1.25% p.a. Under the line of credit agreement, the Company will make monthly payments consisting of $2 of interest, and an annual payment consisting of $2,002 principal plus any accrued interest. The line of credit agreement provides for customary events of default. This line of credit is secured by a $2,100 collateral cash account in the Company’s name at First Republic. As of March 31, 2015, the Company was in compliance with the material terms of this facility. At March 31, 2015, the Company had outstanding borrowings of $2,000. The line of credit matures September 30, 2015. Accordingly, the entire amount is classified as short-term.
	Interest expense under these obligations for the three months ended March 31, 2015 and 2014 was $6 and $4, respectively.
	Indemnification Obligations
	The Company enters into agreements with customers, partners, lenders, consultants, lessors, contractors, sales representatives and parties to certain transactions in the ordinary course of the Company’s business. These agreements may require the Company to indemnify the other party against third party claims alleging that its product infringes a patent or copyright. Certain of these agreements require the Company to indemnify the other party against losses arising from: a breach of representations or covenants, claims relating to property damage, personal injury or acts or omissions of the Company, its employees, agents or representatives. The Company has also agreed to indemnify the directors and certain of the officers and employees in accordance with the by-laws of the Company. These indemnification provisions will vary based upon the nature and terms of the agreements. In many cases, these indemnification provisions do not contain limits on the Company’s liability, and the occurrence of contingent events that will trigger payment under these indemnities is difficult to predict. As a result, the Company cannot estimate its potential liability under these indemnities. The Company believes that the likelihood of conditions arising that would trigger these indemnities is remote and, historically, the Company had not made any significant payment under such indemnification provisions. Accordingly, the Company has not recorded any liabilities relating to these agreements. In certain cases, the Company has recourse against third parties with respect to the aforesaid indemnities, and the Company believes it maintains adequate levels of insurance coverage to protect the Company with respect to potential claims arising from such agreements.

Net_Loss_Per_Common_Share

Net Loss Per Common Share	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Net Loss Per Common Share	7	Net Loss Per Common Share
	Because the Company was in a loss position for each of the periods presented, diluted net loss per share is the same as basic net loss per share for each period as the inclusion of all potential common shares outstanding would have been anti-dilutive. The following outstanding shares of common stock equivalents were excluded from the computation of diluted net loss per share for the periods presented because including them would have been anti-dilutive:
			Three Months ended
			March 31,
			2015		2014
	Weighted average shares outstanding:
	Convertible preferred stock			-		1,266,072
	Convertible preferred stock warrants			-		996,724
	Common stock warrants			359,714		133,377
	Options			717,548		337,500
	Total			1,077,262		2,733,673

Stock_Based_Compensation

Stock Based Compensation	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Stock Based Compensation	8	Stock-Based Compensation
	The Company’s stock-based compensation program is designed to attract and retain employees while also aligning employees' interests with the interests of its stockholders. Stock options have been granted to employees under the stockholder-approved 2007 Key Person Stock Option Plan (“2007 Plan”) or the stockholder-approved 2014 Stock Incentive Plan (“2014 Plan”). Stockholder approval of the 2014 Plan became effective in September 2014. The 2014 Plan provides that the aggregate number of shares of common stock that may be issued pursuant to awards granted under the 2014 Plan may not exceed 450,000 shares (the “Share Reserve”). However, the Share Reserve automatically increases on January 1st of each year, for a period of not more than 10 years, beginning on January 1st of the year following the year in which the 2014 Plan became effective and ending on (and including) January 1, 2024, in an amount equal to 4% of the total number of shares of common stock outstanding on December 31st of the preceding calendar year. The Company’s Board of Directors may act prior to January 1st of a given year to provide that there will be no January 1st increase in the Share Reserve for such year or that the increase in the Share Reserve for such year will be a lesser number of shares of common stock than would otherwise occur. The Share Reserve is currently 638,640 shares for the year ending December 31, 2015.
	In light of stockholder approval of the 2014 Plan, the Company will no longer grant equity awards under the 2007 Plan. As of March 31, 2015, 0 shares of an aggregate total of 407,500 shares were available for future stock-based compensation grants under the 2007 Plan and 332,390 shares of an aggregate total of 638,640 shares were available for future stock-based compensation grants under the 2014 Plan.
	Aggregate intrinsic value represents the difference between the closing market value as of March 31, 2015 of the underlying common stock and the exercise price of outstanding, in-the-money options. A summary of the Company’s stock option activity and related information for 2015 and 2014 is as follows:
			Options Outstanding
			Number of			Weighted		Weighted		Aggregate
			Stock Options			Average		Average		Intrinsic Value
			Outstanding			Exercise Price		Remaining		(in thousands)
								Contractual
								Term (In Years)
	Balance, January 1, 2015			649,500		$	1.49		7.44	$	474
	Options granted			75,000			1.96
	Options canceled			(18,750	)		2.1
	Balance, March 31, 2015			705,750		$	1.52		7.4	$	1,421
	Exercisable as of March 31, 2015			432,729		$	1.18		5.98	$	1,029
	The total compensation cost related to unvested stock option awards not yet recognized was $377 and $0 as of March 31, 2015 and 2014, respectively. The weighted average period over which the total unrecognized compensation cost related to these unvested stock awards is 1.55 years. The total estimated grant date fair value of unvested options was $377 and $0 as of March 31, 2015 and 2014, respectively. The total estimated grant date fair value of options vested during the quarters ended March 31, 2015 and 2014 was $33 and $0, respectively. The weighted average grant date fair value of options granted during the quarter ended March 31, 2015 is $1.38 per share or an aggregate grant date fair value of $104. There were no options granted during the quarter ended March 31, 2014.
	On January 1, 2015 the Company’s Board of Directors granted an option to acquire an aggregate of 75,000 shares under the 2014 Plan. The options vest on a monthly schedule over 48 months such that they are vested in full on the four-year anniversary of the grant date. As of March 31, 2015 there were 325,000 grants, no exercises and 18,750 cancelations of stock options under the 2014 Plan.
	Determining the Fair Value of Stock Options
	The Company uses the Black-Scholes pricing model to determine the fair value of stock options. The fair value of each option grant is estimated on the date of the grant. The fair value of the options granted is estimated on the date of grant using the Black-Scholes pricing model and the following assumptions for the periods presented:
			Quarter ended March 31,
			2015			2014
	Expected term (in years)			5			—
	Risk-free interest rate			1.61	%		—
	Expected volatility			82.5	%		—
	Expected dividend rate			0	%		—
	The assumptions are based on the following for each of the years presented:
	Valuation Method - The Company estimates the fair value of its stock options using the Black-Scholes option pricing model.
	Expected Term - The Company estimates the expected term consistent with the simplified method identified by the SEC. The Company elected to use the simplified method because of its limited history of stock option exercise activity and its stock options meet the criteria of the “plain-vanilla” options as defined by the SEC. The simplified method calculates the expected term as the average of the vesting and contractual terms of the award.
	Volatility - Because the Company has limited trading history by which to determine the volatility of its own common stock price, the expected volatility being used is derived from the historical stock volatilities of a representative industry peer group of comparable publicly listed companies over a period approximately equal to the expected term of the options.
	Risk-free Interest Rate - The risk-free interest rate is based on median U.S. Treasury zero coupon issues with remaining terms similar to the expected term on the options.
	Expected Dividend - The Company has never declared or paid any cash dividends and does not plan to pay cash dividends in the foreseeable future, and therefore, used an expected dividend yield of zero in the valuation model.
	Forfeiture - The Company estimates forfeitures at the time of grant and revises those estimates in subsequent periods if actual forfeitures differ from those estimates. The Company uses historical data to estimate pre-vesting forfeitures and records stock-based compensation expense only for those awards that are expected to vest. All stock-based payment awards are amortized on a straight-line basis over the requisite service periods of the awards, which are generally the vesting periods. If the Company’s actual forfeiture rate is materially different from its estimate, the stock-based compensation expense could be significantly different from what the Company has recorded in the current period.
	The Company has recorded an expense of $33 and $0 as it relates to stock-based compensation for the quarters ended March 31, 2015 and 2014, respectively, which was allocated as follows based on the role and responsibility of the recipient in the Company:
			Three months  ended March 31,
			2015			2014
	Cost of Revenue		$	1		$	-
	Engineering and Product Development			2			-
	Sales and Marketing			15			-
	General and Administrative			15			-
	Total		$	33		$	-

Subsequent_Events

Subsequent Events	3 Months Ended
	Mar. 31, 2015
Subsequent Events [Abstract]
Subsequent Events		9	Subsequent Events
	On April 1, 2015, the Company issued and sold an aggregate of 143,000 shares of its common stock to an accredited investor, pursuant to a stock purchase agreement for an aggregate purchase price of $500,500, which was paid in cash.

Assets_for_Lease_Tables

Assets for Lease (Tables)	3 Months Ended
	Mar. 31, 2015
Leases, Capital [Abstract]
Schedule of assets for lease		March 31,			December 31,
		2015			2014
	Assets for lease	$	988		$	956
	Less: Accumulated Depreciation		(326	)		(283	)
	Assets for lease, net	$	662		$	673

Accrued_Expenses_Tables

Accrued Expenses (Tables)	3 Months Ended
	Mar. 31, 2015
Accrued Liabilities, Current [Abstract]
Schedule of accrued expenses
		March 31,		December 31,
		2015		2014
	Offering Costs	$	317	$	407
	Compensation		569		721
	Miscellaneous Accruals		340		235
	Total Accrued Expenses	$	1,226	$	1,363

Net_Loss_Per_Common_Share_Tabl

Net Loss Per Common Share (Tables)	3 Months Ended
	Mar. 31, 2015
Earnings Per Share [Abstract]
Schedule of common stock equivalents excluded from the computation of diluted net loss per share		Three Months ended
		March 31,
		2015		2014
	Weighted average shares outstanding:
	Convertible preferred stock		-		1,266,072
	Convertible preferred stock warrants		-		996,724
	Common stock warrants		359,714		133,377
	Options		717,548		337,500
	Total		1,077,262		2,733,673

Stock_Based_Compensation_Table

Stock Based Compensation (Tables)	3 Months Ended
	Mar. 31, 2015
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Schedule of summary of stock-based compensation activity
		Options Outstanding
		Number of			Weighted		Weighted		Aggregate
		Stock Options			Average		Average		Intrinsic Value
		Outstanding			Exercise Price		Remaining		(in thousands)
							Contractual
							Term (In Years)
	Balance, January 1, 2015		649,500		$	1.49		7.44	$	474
	Options granted		75,000			1.96
	Options canceled		(18,750	)		2.1
	Balance, March 31, 2015		705,750		$	1.52		7.4	$	1,421
	Exercisable as of March 31, 2015		432,729		$	1.18		5.98	$	1,029
Schedule of weighted-average Black-Scholes fair value assumptions
		Quarter ended March 31,
		2015			2014
	Expected term (in years)		5			—
	Risk-free interest rate		1.61	%		—
	Expected volatility		82.5	%		—
	Expected dividend rate		0	%		—
Schedule of stock-based compensation based on the role and responsibility of the recipient in the Company
		Three months  ended March 31,
		2015			2014
	Cost of Revenue	$	1		$	-
	Engineering and Product Development		2			-
	Sales and Marketing		15			-
	General and Administrative		15			-
	Total	$	33		$	-

Basis_of_Presentation_Detail_T

Basis of Presentation (Detail Textuals) (USD $)	1 Months Ended	3 Months Ended	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Feb. 28, 2014	Mar. 31, 2015	Dec. 31, 2013
Initial public offering
Basis Of Presentation [Line Items]
Number of common stock shares issued	1,430,000
Public offering price per share	$7
Net proceeds from initial public offering	$7,403
Underwriting discounts and commissions	848
Other offering expenses	1,759
Offering expenses		$1,959	$648
Initial public offering | Series A Preferred Stock
Basis Of Presentation [Line Items]
Number of common stock called by warrants		1,067,210
Number of preferred stocks shares converted		1,468,402
Initial public offering | Series A-1 Preferred Stock
Basis Of Presentation [Line Items]
Number of common stock called by warrants		228,656
Number of preferred stocks shares converted		293,750
Initial public offering | Series A-2 Preferred Stock
Basis Of Presentation [Line Items]
Number of preferred stocks shares converted		250,000
Initial public offering | Common Stock
Basis Of Presentation [Line Items]
Number of shares issued for conversion of preferred stock		2,012,152
Aggregate number of common stock shares exercisable at initial public offering		479,115
Over allotment option
Basis Of Presentation [Line Items]
Number of common stock shares issued		214,500
Number of common stock called by warrants		71,500
Exercise price per warrants		$8.75

Going_Concern_Detail_Textuals

Going Concern (Detail Textuals) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Going Concern [Abstract]
Working capital	$1,853
Cash and restricted cash	5,161
Restricted cash	2,100	2,100
Stockholders equity	$2,595	$3,436

Assets_for_Lease_Summary_of_as

Assets for Lease - Summary of assets for lease (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Leases, Capital [Abstract]
Assets for lease	$988	$956
Less: Accumulated Depreciation	-326	-283
Assets for lease, net	$662	$673

Assets_for_Lease_Detail_Textua

Assets for Lease (Detail Textuals) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Leases, Capital [Abstract]
Depreciation expense	$57	$47
Reduction to accumulated depreciation for returned items	$14	$16

Deferred_Financing_Costs_Detai

Deferred Financing Costs (Detail Textuals) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Dec. 31, 2014
Deferred Finance Costs [Abstract]
Deferred financing costs	$37		$55
Amortized interest expense	$18	$23

Accrued_Expenses_Summary_of_ac

Accrued Expenses - Summary of accrued expenses (Details) (USD $)	Mar. 31, 2015	Dec. 31, 2014
In Thousands, unless otherwise specified
Accrued Liabilities, Current [Abstract]
Offering Costs	$317	$407
Compensation	569	721
Miscellaneous Accruals	340	235
Total Accrued Expenses	$1,226	$1,363

Commitments_and_Contingencies_

Commitments and Contingencies (Detail Textuals) (USD $)	1 Months Ended	3 Months Ended
	Sep. 23, 2014	Mar. 31, 2015
Commitments and Contingencies Disclosure [Abstract]
Facilities lease expense		$32,000
Term specified for lease agreement	36 months
Future lease payments for December 31, 2015		186.6
Future lease payments for December 31, 2016		209.1
Future lease payments for December 31, 2017		215.4
Future lease payments for December 31, 2018		18
February 2015 to January 2016
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement	17
February 2016 to January 2017
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement	17.5
February 2017 to January 2018
Property Subject to or Available for Operating Lease [Line Items]
Payments required per month under terms of lease agreement	18

Commitments_and_Contingencies_1

Commitments and Contingencies (Detail Textuals 1) (USD $)	3 Months Ended		0 Months Ended	1 Months Ended	12 Months Ended	1 Months Ended	0 Months Ended	1 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Feb. 09, 2011	27-May-11	Dec. 31, 2011	Jun. 17, 2011	Sep. 13, 2011	Sep. 30, 2014	Dec. 31, 2014
Commitments And Contingencies [Line Items]
Restricted cash	$2,100								$2,100
Interest expense	6	4
Secured Debt | Equipment Finance Agreement | U.S. Bancorp Business Equipment Finance Group
Commitments And Contingencies [Line Items]
Amount of secured loan obtained			39	109
Term of secured loan			48 months	60 months
Annual fixed interest rate			13.00%	6.00%
Monthly principal payment			1	2
Frequency of payment			Monthly	Monthly
Amount of outstanding borrowings	50
Secured Debt | Equipment Finance Agreement | U.S. Bancorp Business Equipment Finance Group
Commitments And Contingencies [Line Items]
Amount of outstanding borrowings	10
Secured Debt | Lease Agreements | Lease Corporation of America
Commitments And Contingencies [Line Items]
Amount of secured loan obtained					66
Term of secured loan					60 months
Annual fixed interest rate					14.00%
Monthly principal payment					1
Frequency of payment					Monthly
Amount of outstanding borrowings	40
Secured Debt | Loan Agreement | First Republic Bank
Commitments And Contingencies [Line Items]
Amount of secured loan obtained						150
Term of secured loan						60 months
Annual variable interest rate						1.75%
Floor interest rate on loan						3.25%
Description of interest rates						Prime rate
Annual fixed interest rate						5.00%
Monthly principal payment						3
Frequency of payment						Monthly
Amount of outstanding borrowings	68
Secured Debt | Additional Loan Agreements | First Republic Bank
Commitments And Contingencies [Line Items]
Amount of secured loan obtained							150
Term of secured loan							60 months
Annual variable interest rate							1.75%
Floor interest rate on loan							3.25%
Description of interest rates							Prime rate
Annual fixed interest rate							5.00%
Monthly principal payment							3
Frequency of payment							Monthly
Amount of outstanding borrowings	75
Secured Debt | Line Of Credit Agreement | First Republic Bank | Revolving Credit Facility
Commitments And Contingencies [Line Items]
Maximum limit of borrowing								2,000
Term of secured loan								12 months
Floor interest rate on loan								2.00%
Description of interest rates								Prime rate
Annual fixed interest rate								1.25%
Monthly principal payment								2,002
Monthly interest payment								2
Frequency of payment								Monthly
Amount of outstanding borrowings	2,000
Restricted cash								$2,100

Net_Loss_Per_Common_Share_Summ

Net Loss Per Common Share - Summary of outstanding shares of common stock equivalents excluded from the computation of diluted net loss per share (Details)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Weighted average shares outstanding:
Total	1,077,262	2,733,673
Convertible preferred stock
Weighted average shares outstanding:
Total		1,266,072
Convertible preferred stock warrants
Weighted average shares outstanding:
Total		996,724
Common stock warrants
Weighted average shares outstanding:
Total	359,714	133,377
Options
Weighted average shares outstanding:
Total	717,548	337,500

Stock_Based_Compensation_Summa

Stock Based Compensation - Summary of stock-based compensation activity (Details) (USD $)	3 Months Ended	12 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Dec. 31, 2014
Number of Stock Options Outstanding
Balance, January 1, 2015	649,500
Options granted	75,000
Options canceled	-18,750
Balance, March 31, 2015	705,750	649,500
Exercisable as of March 31, 2015	432,729
Weighted Average Exercise Price
Outstanding at January 1, 2015	$1.49
Granted	$1.96
Options canceled	$2.10
Balance, March 31, 2015	$1.52	$1.49
Exercisable as of March 31, 2015	$1.18
Options Outstanding , Weighted Average Remaining Contractual Term (in years)	7 years 4 months 24 days	7 years 5 months 8 days
Exercisable, Weighted Average Remaining Contractual Term (in years)	5 years 11 months 23 days
Options Outstanding, Aggregate Intrinsic Value	$1,421	$474
Exercisable, Aggregate Intrinsic Value	$1,029

Stock_Based_Compensation_Weigh

Stock Based Compensation - Weighted-average Black-Scholes fair value assumptions (Details 1)	3 Months Ended
	Mar. 31, 2015	Mar. 31, 2014
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]
Expected term (in years)	5 years
Risk-free interest rate	1.61%
Expected volatility	82.50%
Expected dividend rate	0.00%

Stock_Based_Compensation_Stock

Stock Based Compensation - Stock-based compensation (Details 2) (USD $)	3 Months Ended
In Thousands, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$33
Cost of Revenue
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	1
Engineering and Product Development
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	2
Sales and Marketing
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	15
General and Administrative
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$15

Stock_Based_Compensation_Detai

Stock Based Compensation (Detail Textuals) (USD $)	3 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$33
Fair value method	Black-Scholes pricing model
Total unrecognized compensation cost related to non-vested awards	377	0
Weighted average period of unvested stock awards	1 year 6 months 18 days
Total estimated grant date fair value of options vested	377	0
Weighted average grant date fair value of options granted	$1.38
Aggregate grant date fair value	$104
Employee stock option | 2007 Key Person Stock Option Plan ("2007 Plan")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares available for future stock-based compensation grants	0
Aggregate number of shares	407,500
Employee stock option | 2014 Stock Incentive Plan ("2014 Plan")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Percentage of shares reserve increase	4.00%
Number of shares in reserve	638,640
Shares available for future stock-based compensation grants	332,390
Aggregate number of shares	450,000
Term of stock option grants	10 years

Stock_Based_Compensation_Detai1

Stock Based Compensation (Detail Textuals 1) (USD $)	3 Months Ended		1 Months Ended
In Thousands, except Share data, unless otherwise specified	Mar. 31, 2015	Mar. 31, 2014	Jan. 31, 2015
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Stock-based compensation expense	$33
Number of stock options granted	75,000
Employee stock option | 2014 Stock Incentive Plan ("2014 Plan")
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of stock options granted	325,000		75,000
Number of stock options cancelled	18,750
Vesting period of option			48 months

Subsequent_Events_Detail_Textu

Subsequent Events (Detail Textuals) (Subsequent Event, Stock Purchase Agreement, Accredited Investor, USD $)	0 Months Ended
In Thousands, except Share data, unless otherwise specified	Apr. 01, 2015
Subsequent Event | Stock Purchase Agreement | Accredited Investor
Subsequent Event [Line Items]
Number of common stock shares issued	143,000
Aggregate purchase price of common stock issued	$500,500